ArticleOncoimmunology2020
A rationally-engineered IL-2 improves the antitumor effect of anti-CD20 therapy.
Ana Victoria Casadesús et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
4 papers cite it
this papercites it
ArticleOncoimmunology2020
Ana Victoria Casadesús et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.